Evaluation of a prolonged prothrombin time

Clinical Chemistry

Volumn 54, Issue 4, 2008, Pages 765-768

  Hood, Joshua L ^a   Eby, Charles S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7;

ADULT; ANAMNESIS; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING FACTOR 7 DEFICIENCY; BLOOD CLOTTING TEST; CAPILLARY RESISTANCE; CASE REPORT; CLINICAL FEATURE; HUMAN; MALE; PROTHROMBIN TIME; TOTAL HIP PROSTHESIS; FEMALE; MIDDLE AGED;

FACTOR VII DEFICIENCY; FEMALE; HUMANS; MIDDLE AGED; PROTHROMBIN TIME;

EID: 42449142326     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2007.100818     Document Type: Article

References (9)

1. Kamal AH, Tefferi A, Pruthi RK. How to interpret and pursue an abnormal prothrombin time, activated partial thromboplastin time, and bleeding time in adults. Mayo Clin Proc 2007;82:864-73.
2. Mullighan CG, Rischbieth A, Duncan EM, Lloyd JV. Acquired isolated factor VII deficiency associated with severe bleeding and successful treatment with recombinant FVIIa (NovoSeven). Blood Coag Fibrinol 2004;15:347-51.
3. Giansily-Blaizot M, Schved J-F. Potential predictors of bleeding risk in inherited factor VII deficiency: clinical, biological and molecular criteria. Thromb Haemostasis 2005;94:901-6.
4. McVey JH, Boswell EM, Mumford AD, Kemball-Cook G, Tuddenham GD. Factor VII deficiency and the FVII mutation. Human Mutation 2001;17:3-17.
5. Girolami A, Fabris F, Dal Bo Zanon R, Ghiotto G, Burul A. Factor VII Padua: a congenital coagulation disorder due to an abnormal factor VII with a peculiar activation pattern. J Lab Clin Med 1978;91:387-95.
6. O'Brien DP, Gale KM, Anderson JS, McVey JH, Miller GJ, Meade TW, Tuddenham EGD. Purification and characterization of factor VII 304-Gln: a variant molecule with reduced activity isolated from a clinically unaffected male. Blood 1991;78(1):132-40.
7. Mariani G, Konkle BA, Ingerslev J. Congenital factor VII deficiency: therapy with recombinant activated factor VII-a critical appraisal. Haemophilia 2006; 12:19-27.
8. Gopalan PK, Clohisy JC, Cashen AF, Eby CS. Use of recombinant factor VIIa for hip surgery in a patient with factor-VII deficiency: a case report. J Bone Joint Surg Am 2007;89A(2):389-91.
9. Bolton-Maggs PHB, Perry DJ, Chalmers EA, Parapia LA, Wilde JT, Williams MD, et al. The rare coagulation disorders-review with guidelines for management from the United Kingdom Haemophila Center Doctors' Organization. Haemophilia 2004;10:593-628.